CNSide is excited to exhibit at the Best of ASCO Austin event, where healthcare professionals can connect, learn, and explore advances in oncology education and diagnostics. This free CME opportunity is a valuable chance to stay current on clinical insights while...
Emerging Health Economics Data Suggest Earlier LM Detection May Reduce Healthcare Costs Leptomeningeal metastases (LM) remains one of the most challenging and resource-intensive complications in oncology, often associated with delayed diagnosis, complex management,...
Connecting with the Neuro-Oncology Community at AACR’s Brain Cancer Research Conference CNSide Diagnostics is looking forward to attending the upcoming AACR Special Conference in Cancer Research: Brain Cancer in Philadelphia. Hosted by the American Association for...
Recognizing the Experts Driving Innovation in Leptomeningeal Metastases Diagnostics On Employee Appreciation Day, we want to recognize and thank the incredible CNSide® team members whose dedication, expertise, and hard work continue to support the commercialization...
Honoring Scientific Leaders in Cancer Diagnostics and Leptomeningeal Metastases Innovation On International Day of Women and Girls in Science, we are proud to recognize the exceptional women across the CNSide® Diagnostics and Plus Therapeutics teams who are helping...
New lab licenses strengthen nationwide access to CNS oncology diagnostics Plus Therapeutics (NASDAQ: PSTV) has announced a major regulatory and commercialization milestone with the expansion of laboratory licenses for its CNSide® Cerebrospinal Fluid (CSF) Tumor Cell...
Expanding operational and regulatory expertise to support commercialization and growth Plus Therapeutics (NASDAQ: PSTV) today announced two key leadership additions to CNSide Diagnostics, its wholly-owned subsidiary, further strengthening the company’s operational...
Strengthening CNS oncology diagnostics at the heart of America’s largest medical ecosystem CNSide Diagnostics, a subsidiary of Plus Therapeutics (NASDAQ: PSTV), has officially expanded into Levit Green, a premier life sciences innovation campus developed by Hines in...
In the evolving landscape of central nervous system (CNS) oncology, the integration of advanced diagnostic technologies with precision therapeutic innovation is reshaping how clinicians detect, monitor, and manage complex CNS cancers. At CNSide Diagnostics, we are...
